Karoo Health is a technology company.
Karoo Health has raised $4.0M across 2 funding rounds.
Karoo Health has raised $4.0M in total across 2 funding rounds.
Karoo Health is a technology-enabled platform delivering value-based cardiovascular care, combining on-site and virtual care teams with proprietary digital tools like Kohere.ai to manage high-risk cardiac patients.[1][2][3][6] It serves cardiology networks, health systems, and health plans, solving the challenge of transitioning to outcomes-driven contracts by improving patient health, reducing ER visits (e.g., ~30% in pilots), and lowering costs in the cardiology vertical.[1][3][4] Founded in 2021 and based in Albuquerque, NM, the company has shown strong growth: seed funding in June 2023, partnerships like a 2024 joint venture with Heartbeat Health for nationwide coverage, expansion to ~5 states with 500+ provider partners by March 2025, and selection for Zing Health's multi-state Medicare Advantage cardiac program.[4][5]
Karoo Health was founded in 2021 in Albuquerque, New Mexico, by CEO and cofounder Ian Koons, emerging from a focus on perfecting a value-based care model before layering on technology.[3][4][5] The idea stemmed from the need to enable cardiology groups, payers, and risk-bearing entities to succeed in cardiac value-based contracts amid rising healthcare costs and shifts to outcomes-based payment models.[1][4] Early traction built quickly: pilots in late 2023 achieved >80% patient enrollment and ~30% ER reductions; June 2023 marked seed funding and official launch; early 2024 brought the Kohere.ai platform debut with 89% patient conversion, 99% digital engagement, and 23% ED diversion in proofs-of-concept; May 2024 sealed a pivotal joint venture with Heartbeat Health for 24/7 national telecardiology; and by March 2025, it spanned ~5 states with 500+ providers.[3][4]
Karoo stands out in cardiac value-based care (VBC) through its hybrid, tech-amplified model:
Karoo rides the explosive growth of value-based healthcare, projected from $1.63 trillion in 2024 to $3.77 trillion by 2029 (18% CAGR), driven by payer shifts to outcomes-based contracts, Medicare Advantage expansion, and cardiology's high-cost burden (e.g., preventing ER/stroke events).[3][4] Timing aligns with post-pandemic telehealth adoption and AI integration in care, where hybrids like Karoo's outpace pure digital plays by embedding into workflows.[2][3] It influences the ecosystem as a specialty enabler—mirroring kidney care models—via partnerships (e.g., Zing Health), accelerating VBC for Medicare populations without providers building from scratch, and setting benchmarks with published metrics amid fragmented cardiology tech.[4]
Karoo Health is positioned for national scale, leveraging Kohere.ai's AI roadmap, Heartbeat's network, and VBC tailwinds to expand beyond 5 states into more Medicare Advantage deals and health systems.[3][4] Trends like AI-driven predictive care, payer consolidation, and specialty VBC (e.g., rivals Ventricle Health, CardioOne) will shape it, potentially amplifying its ER reductions and cost savings at population levels.[2][4] Its influence may evolve from enabler to full-stack cardiac VBC leader, supercharging transitions for providers in a $3T+ market—cementing its role as the tech backbone for value-based cardiology success.[1][3]
Karoo Health has raised $4.0M in total across 2 funding rounds.
Karoo Health's investors include BIP Capital.
Karoo Health has raised $4.0M across 2 funding rounds. Most recently, it raised $3.0M Seed in June 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2023 | $3.0M Seed | BIP Capital | |
| Apr 1, 2022 | $1.0M Seed | BIP Capital |